Advertisement

Topics

Trevena, Inc. Company Profile

09:03 EST 10th December 2018 | BioPortfolio

Trevena, Inc. is a leader in the discovery and development of GPCR biased ligand drugs. Trevena combines a powerful and efficient drug discovery platform with extensive development experience to yield a rich linked portfolio of novel medicines. Trevena’s proprietary Advanced Biased Ligand Explorer, or ABLE™, platform includes customized assays, proprietary software, animal models and unique biological signaling information across multiple GPCRs that allow for the discovery, optimization and development of unique biased ligands into differentiated new medicines. The company’s drug discovery technology is based on extensive research from the laboratories of leading scientists in the GPCR field - Robert J. Lefkowitz, M.D. and Howard A. Rockman, M.D. of Duke University Medical Center. Trevena’s pipeline is currently focused on programs for cardiovascular and CNS indications with significant unmet medical needs. Founded in 2008, Trevena is based in King of Prussia, Pennsylvania and is a privately held company backed by leading investors including Alta Partners, Healthcare Ventures, NEA, Polaris and Yasuda Enterprise Development Company. For more information about the company, please visit www.trevenainc.com.


News Articles [78 Associated News Articles listed on BioPortfolio]

Investor Alert: Kaplan Fox Announces Investigation Of Trevena Inc.

NEW YORK, Nov. 2, 2018 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Trevena Inc. ("Trevena" or Read more...

Deals this week: Trevena, Compugen, Biohaven Pharmaceutical

Trevena plans to raise $175m through a public offering of securities. Trevena plans to issue common stock, debt securities, and...Read More... The post Deals this week: Trevena, Compugen, Biohaven Pha...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Trevena, Inc. of Class Action Lawsuit and Upcoming Deadline - TRVN

NEW YORK, Nov. 7, 2018 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Trevena Inc. ("Trevena or the "Company") (NASDAQ: TRVN) and certain of its officer...

Trevena goes for MOR than morphine

A split panel on Trevena’s pain candidate oliceridine likely won’t do much to turn FDA’s skepticism, but leaves a chance for the company to bolster its case with more data.

After FDA Advisory Committee Rejection, Trevena Now Faces a Class Action Lawsuit

Things seem to have gone from bad to worse for Pennsylvania-based Trevena, Inc. This week the company saw a U.S. Food and Drug Administration advisory committee reject its intravenous pain treatment a...

Trevena shares sink on FDA concerns ahead of key panel meeting

Briefing documents from FDA staff revealed the agency hadn't agreed to parts of Trevena's plans to measure its candidate's safety profile. 

Trevena Aktie: Abwarten!

Nachdem Trevena die Zulassung für ein Schmerzmittel in den USA verweigert wurde, haben viele Anleger den Titel schon ganz und gar abgeschrieben. Das zeigt sich deutlich am Aktienkurs, der allein am.....

Trevena opioid painkiller fails to win FDA approval

Trevena Inc said on Friday the U.S. Food and Drug Administration declined to approve its opioid injection for managing acute pain.

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Trevena Inc.

Trevena, Inc. is a leader in the discovery and development of GPCR biased ligand drugs. Trevena combines a powerful and efficient drug discovery platform with extensive developmen...

Trevena, Inc.

Trevena, Inc. is a leader in the discovery and development of GPCR biased ligand drugs. Trevena combines a powerful and efficient drug discovery platform with extensive developmen...

More Information about "Trevena, Inc." on BioPortfolio

We have published hundreds of Trevena, Inc. news stories on BioPortfolio along with dozens of Trevena, Inc. Clinical Trials and PubMed Articles about Trevena, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Trevena, Inc. Companies in our database. You can also find out about relevant Trevena, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record